Literature DB >> 20937450

Prevention, diagnosis, and treatment of hypertensive heart disease.

Vasiliki V Georgiopoulou1, Andreas P Kalogeropoulos, Paolo Raggi, Javed Butler.   

Abstract

Hypertensive heart disease (HHD), a result of long-standing hypertension, is characterized by changes in the myocardial structure and function in the absence of other primary cardiovascular abnormalities. Although increased blood pressure is the initiating stimulus, neurohormonal factors, particularly the renin-angiotensin system, play a key role in remodeling of cardiac chamber geometry and walls. Optimal antihypertensive therapy in the setting of therapeutic lifestyle changes is crucial in the prevention and control of HHD. Regression of left ventricular hypertrophy (LVH) is achievable and associated with improved prognosis. However, prevention of myocardial remodeling before LVH establishes would further increase the benefits to cardiac function and prognosis. Antihypertensive agents exhibit variable effectiveness in inducing LVH regression. Currently, renin-angiotensin system blocking agents seem to be the most effective approach for LVH regression and reverse remodeling in these patients.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20937450     DOI: 10.1016/j.ccl.2010.07.005

Source DB:  PubMed          Journal:  Cardiol Clin        ISSN: 0733-8651            Impact factor:   2.213


  9 in total

1.  Trends in mortality rates by subtypes of heart disease in the United States, 2000-2010.

Authors:  Matthew D Ritchey; Fleetwood Loustalot; Barbara A Bowman; Yuling Hong
Journal:  JAMA       Date:  2014-11-19       Impact factor: 56.272

Review 2.  Alterations in cardiac structure and function in hypertension.

Authors:  Mário Santos; Amil M Shah
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

3.  Impact of Body Mass Index >50 on Cardiac Structural and Functional Characteristics and Surgical Outcomes After Bariatric Surgery.

Authors:  Nicholas Keisuke Brownell; Marcela Rodriguez-Flores; Eduardo Garcia-Garcia; Samuel Ordoñez-Ortega; Jorge Oseguera-Moguel; Carlos A Aguilar-Salinas; Paul Poirier
Journal:  Obes Surg       Date:  2016-11       Impact factor: 4.129

4.  Differential Expression of Hypertensive Phenotypes in BXD Mouse Strains in Response to Angiotensin II.

Authors:  Wenyuan Zhao; Tieqiang Zhao; Yuanjian Chen; Syamal K Bhattacharya; Lu Lu; Yao Sun
Journal:  Am J Hypertens       Date:  2017-12-08       Impact factor: 2.689

Review 5.  Recent Advances in Imaging of Hypertensive Heart Disease.

Authors:  Christopher L Schumann; Nicholas R Jaeger; Christopher M Kramer
Journal:  Curr Hypertens Rep       Date:  2019-01-14       Impact factor: 5.369

6.  Study on the correlation between Left Ventricular Hypertrophy and Coronary Artery disease in the very elderly patients with hypertension.

Authors:  Jian-Hua Sun; Xiao-Kun Liu; Qi Zhang; Qing-Hua Zhang
Journal:  Pak J Med Sci       Date:  2021 Sep-Oct       Impact factor: 1.088

7.  The Trends in Cardiovascular Diseases and Respiratory Diseases Mortality in Urban and Rural China, 1990-2015.

Authors:  Weiwei Sun; Yun Zhou; Zhuang Zhang; Limin Cao; Weihong Chen
Journal:  Int J Environ Res Public Health       Date:  2017-11-15       Impact factor: 3.390

8.  Hydrogen Sulfide Regulates Krüppel-Like Factor 5 Transcription Activity via Specificity Protein 1 S-Sulfhydration at Cys664 to Prevent Myocardial Hypertrophy.

Authors:  Guoliang Meng; Yujiao Xiao; Yan Ma; Xin Tang; Liping Xie; Jieqiong Liu; Yue Gu; Ying Yu; Chung-Min Park; Ming Xian; Xin Wang; Albert Ferro; Rui Wang; Philip K Moore; Zhiren Zhang; Hong Wang; Yi Han; Yong Ji
Journal:  J Am Heart Assoc       Date:  2016-09-16       Impact factor: 5.501

9.  Association of body mass index with left ventricular diastolic dysfunction among ambulatory individuals with diabetes mellitus in rural Uganda: a cross-sectional study.

Authors:  Boniface Amanee Elias Lumori; Edwin Nuwagira; Fardous Charles Abeya; Abdirahman Ali Araye; Godfrey Masette; Charles K Mondo; Samson Okello; Conrad Muzoora; Anthony Muyingo
Journal:  BMC Cardiovasc Disord       Date:  2022-06-20       Impact factor: 2.174

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.